ximelagatran and Liver-Failure--Acute

ximelagatran has been researched along with Liver-Failure--Acute* in 1 studies

Other Studies

1 other study(ies) available for ximelagatran and Liver-Failure--Acute

Article	Year
'Hy's law,' the 'Rezulin Rule,' and other predictors of severe drug-induced hepatotoxicity: putting risk-benefit into perspective. Pharmacoepidemiology and drug safety, 2006, Volume: 15, Issue:4 Topics: Alanine Transaminase; Anticoagulants; Azetidines; Benzylamines; Bilirubin; Biomarkers; Chemical and Drug Induced Liver Injury; Chromans; Drug Approval; Humans; Hypoglycemic Agents; Jaundice; Liver; Liver Failure, Acute; Pharmacoepidemiology; Predictive Value of Tests; Risk Assessment; Thiazolidinediones; Troglitazone; United States; United States Food and Drug Administration	2006

Article

Year

'Hy's law,' the 'Rezulin Rule,' and other predictors of severe drug-induced hepatotoxicity: putting risk-benefit into perspective.

Pharmacoepidemiology and drug safety, 2006, Volume: 15, Issue:4

Topics: Alanine Transaminase; Anticoagulants; Azetidines; Benzylamines; Bilirubin; Biomarkers; Chemical and Drug Induced Liver Injury; Chromans; Drug Approval; Humans; Hypoglycemic Agents; Jaundice; Liver; Liver Failure, Acute; Pharmacoepidemiology; Predictive Value of Tests; Risk Assessment; Thiazolidinediones; Troglitazone; United States; United States Food and Drug Administration

2006